| MEPS HC 248A CODEBOOK |
| 2023 PRESCRIBED MEDICINES |
| DATE: June 13, 2025 |
| Variable Name: |
TC1S1 |
| Description: |
MULTUM THERAPEUTIC SUB-CLASS #1 FOR TC1 |
| Format: |
3.0 |
| Type: |
NUM |
| Start: |
431 |
| End: |
433 |
|
|
|
| -15 CANNOT BE COMPUTED |
5,070 |
80,742,802 |
| -1 INAPPLICABLE |
5,180 |
75,271,800 |
| 2 AMEBICIDES |
95 |
1,469,389 |
| 4 ANTIFUNGALS |
367 |
5,389,528 |
| 5 ANTIMALARIAL AGENTS |
905 |
13,484,466 |
| 7 ANTIVIRAL AGENTS |
1,359 |
22,087,909 |
| 9 CEPHALOSPORINS |
786 |
12,284,106 |
| 11 MACROLIDE DERIVATIVES |
601 |
10,557,180 |
| 12 MISCELLANEOUS ANTIBIOTICS |
8 |
136,477 |
| 13 PENICILLINS |
1,873 |
34,660,040 |
| 14 QUINOLONES |
284 |
4,016,973 |
| 15 SULFONAMIDES |
285 |
4,675,187 |
| 17 URINARY ANTI-INFECTIVES |
313 |
4,889,422 |
| 19 ANTIHYPERLIPIDEMIC AGENTS |
15,781 |
223,326,375 |
| 23 ANTIMETABOLITES |
326 |
4,630,961 |
| 24 ANTINEOPLASTIC HORMONES |
607 |
8,708,446 |
| 25 MISCELLANEOUS ANTINEOPLASTICS |
131 |
2,045,025 |
| 42 ANGIOTENSIN CONVERTING ENZYME INHIBITORS |
5,879 |
85,104,139 |
| 43 ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING |
343 |
4,724,822 |
| 44 ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
641 |
9,167,086 |
| 45 ANTIANGINAL AGENTS |
639 |
8,885,526 |
| 46 ANTIARRHYTHMIC AGENTS |
1,945 |
27,609,948 |
| 47 BETA-ADRENERGIC BLOCKING AGENTS |
6,549 |
91,875,065 |
| 48 CALCIUM CHANNEL BLOCKING AGENTS |
5,202 |
74,114,815 |
| 49 DIURETICS |
5,623 |
74,436,353 |
| 51 MISCELLANEOUS CARDIOVASCULAR AGENTS |
48 |
594,497 |
| 53 VASODILATORS |
456 |
6,353,913 |
| 54 VASOPRESSORS |
129 |
2,016,699 |
| 55 ANTIHYPERTENSIVE COMBINATIONS |
2,488 |
35,053,075 |
| 56 ANGIOTENSIN II INHIBITORS |
5,281 |
78,943,334 |
| 58 ANALGESICS |
11,526 |
171,604,910 |
| 64 ANTICONVULSANTS |
8,187 |
118,839,288 |
| 65 ANTIEMETIC/ANTIVERTIGO AGENTS |
1,333 |
21,695,392 |
| 66 ANTIPARKINSON AGENTS |
431 |
5,349,311 |
| 67 ANXIOLYTICS, SEDATIVES, AND HYPNOTICS |
4,374 |
72,014,384 |
| 71 CNS STIMULANTS |
3,605 |
66,602,566 |
| 73 MUSCLE RELAXANTS |
2,510 |
37,733,558 |
| 80 MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENT |
270 |
3,923,362 |
| 82 ANTICOAGULANTS |
2,531 |
33,367,316 |
| 83 ANTIPLATELET AGENTS |
1,251 |
18,100,698 |
| 88 ANTACIDS |
244 |
3,394,653 |
| 90 ANTIDIARRHEALS |
130 |
2,368,822 |
| 91 DIGESTIVE ENZYMES |
56 |
1,076,565 |
| 94 H2 ANTAGONISTS |
1,092 |
16,904,206 |
| 95 LAXATIVES |
764 |
11,288,202 |
| 96 MISCELLANEOUS GI AGENTS |
151 |
1,767,332 |
| 98 ADRENAL CORTICAL STEROIDS |
1,758 |
26,364,204 |
| 99 ANTIDIABETIC AGENTS |
16,973 |
247,955,203 |
| 101 SEX HORMONES |
3,044 |
58,599,643 |
| 103 THYROID HORMONES |
5,579 |
86,760,407 |
| 106 ANTIDOTES |
10 |
123,390 |
| 116 IRON PRODUCTS |
775 |
11,015,023 |
| 117 MINERALS AND ELECTROLYTES |
1,350 |
18,248,067 |
| 119 VITAMINS |
3,088 |
41,862,980 |
| 120 VITAMIN AND MINERAL COMBINATIONS |
343 |
5,316,183 |
| 123 ANTIHISTAMINES |
1,831 |
25,429,536 |
| 124 ANTITUSSIVES |
337 |
5,241,122 |
| 125 BRONCHODILATORS |
7,298 |
102,074,277 |
| 127 DECONGESTANTS |
41 |
497,308 |
| 128 EXPECTORANTS |
42 |
511,688 |
| 130 RESPIRATORY INHALANT PRODUCTS |
404 |
5,474,052 |
| 132 UPPER RESPIRATORY COMBINATIONS |
271 |
4,535,228 |
| 135 ANTISEPTIC AND GERMICIDES |
60 |
950,297 |
| 136 DERMATOLOGICAL AGENTS |
3,260 |
49,902,387 |
| 146 MOUTH AND THROAT PRODUCTS |
70 |
1,132,748 |
| 147 OPHTHALMIC PREPARATIONS |
3,373 |
47,276,776 |
| 148 OTIC PREPARATIONS |
102 |
1,761,325 |
| 151 VAGINAL PREPARATIONS |
4 |
98,669 |
| 192 ANTIRHEUMATICS |
244 |
3,900,242 |
| 194 ANTIGOUT AGENTS |
1,134 |
16,321,942 |
| 219 NUTRACEUTICAL PRODUCTS |
230 |
3,371,506 |
| 220 HERBAL PRODUCTS |
133 |
2,245,427 |
| 240 LINCOMYCIN DERIVATIVES |
91 |
1,347,626 |
| 243 LEUKOTRIENE MODIFIERS |
1,679 |
25,893,502 |
| 247 NASAL PREPARATIONS |
1,683 |
23,431,960 |
| 249 ANTIDEPRESSANTS |
13,109 |
208,729,198 |
| 251 ANTIPSYCHOTICS |
2,025 |
30,815,378 |
| 264 URINARY ANTISPASMODICS |
881 |
11,729,637 |
| 266 MISCELLANEOUS GENITOURINARY TRACT AGENTS |
50 |
827,434 |
| 272 PROTON PUMP INHIBITORS |
6,248 |
89,621,036 |
| 277 5-AMINOSALICYLATES |
266 |
4,080,189 |
| 288 5-ALPHA-REDUCTASE INHIBITORS |
684 |
9,051,953 |
| 293 GLUCOSE ELEVATING AGENTS |
1 |
4,481 |
| 303 AGENTS FOR PULMONARY HYPERTENSION |
407 |
6,232,771 |
| 312 CHOLINERGIC AGONISTS |
46 |
520,948 |
| 313 CHOLINESTERASE INHIBITORS |
468 |
6,022,428 |
| 320 SMOKING CESSATION AGENTS |
1,810 |
30,896,722 |
| 355 FUNCTIONAL BOWEL DISORDER AGENTS |
501 |
6,908,382 |
| 363 PROBIOTICS |
4 |
34,318 |
| 397 MULTIKINASE INHIBITORS |
7 |
79,865 |
| 401 CD20 MONOCLONAL ANTIBODIES |
31 |
335,650 |
| 403 MTOR INHIBITORS |
21 |
542,049 |
| 409 BONE RESORPTION INHIBITORS |
528 |
6,988,065 |
| 422 ANTITHYROID AGENTS |
83 |
1,128,559 |
| 460 PHOSPHATE BINDERS |
12 |
138,814 |
| 482 ANGIOTENSIN RECEPTOR BLOCKERS AND NEPRILY |
186 |
2,442,362 |
| 504 ANTIMANIC AGENTS |
165 |
2,680,152 |
| 516 NORADRENERGIC UPTAKE INHIBITORS FOR ADHD |
154 |
3,431,316 |
| 519 ALPHA-ADRENORECEPTOR ANTAGONISTS |
1,732 |
24,250,534 |
| TOTAL |
192,275 |
2,858,420,881 |
Return to list of variables
|
Back
Email Updates